The definitive guide to gene editing.
Menu
Home Learn News Ask the Atlas
Explore Technologies Diseases Treatments Clinical Trials Companies Scientists Genes Research Institutions
Beyond medicine Agriculture Ethics Investing World map
Learn & Tools Start here Glossary A–Z Compare technologies Timeline Lists & Rankings AI Agents ★ Saved API
About About us Methodology Data Sources Editorial Policy Contact Disclaimers

🧭 Guided View
New to genetics? We explain every term as you browse, in plain English. Same pages, with the help built in.

⚡ Expert View
You already know the biology. Just the content — clean and compact, no extra explanations. This is the default view.

Interface language
Light mode

Gene · Immune

B2M

Beta-2 microglobulin — A required component of MHC class I; removing it hides transplanted cells from the recipient's killer T cells.

15q21.1 cell therapyhypoimmune
Chromosome 15 B2M 15q21.1 p q

Schematic only — arm proportions are approximate and band detail is not drawn to scale. Cytogenetic location as published by NCBI Gene.

What this gene does

Every cell displays samples of what is inside it on its surface, on structures the immune system inspects. B2M is a necessary part of those structures — delete it and the display disappears, so the recipient's T cells cannot identify the cell as foreign. The catch is that natural killer cells are specifically alarmed by cells with no display, which is why hypoimmune designs add a second signal to reassure them.

B2M, at 15q21.1, encodes beta-2 microglobulin, an obligate component of MHC class I. Knockout abolishes surface class I expression, evading CD8 T-cell recognition of allogeneic cells, but triggers natural killer 'missing self' surveillance — which hypoimmune platforms counter by overexpressing CD47 or retaining HLA-E.

Sources

Connected in the Atlas

Every entry on this site is linked to the others it relates to. These connections are part of the record, not a search result.